Rachel Sisodia, MD: Why Female Leadership Matters in Health Care
Episode #[XX] of the Charged podcast
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
As a Gynecologic Oncologist my expertise is in performing complex surgeries and administering oncologic treatments for cancers of the ovary, uterus, cervix, vulva, vagina and other conditions. As a physician, I feel it is our duty to be incredibly kind to our patients and to partner with them to fight this challenge together, as a team. My deepest commitment is to perform each woman's surgery expertly and in pursuit of the best possible outcome that we can obtain for her, while minimizing the risk of complications. I leverage this commitment to quality of care in my work as the Chief Quality Officer for Mass General Brigham. In this role I am responsible for the quality and safety of all health care provided throughout our system, spanning thirteen hospitals, thousands of physicians, and millions of patient lives. While my clinical interest is primarily in providing high quality, safe, excellent surgical and clinical care, as a mother myself, I also have a particular passion in utilizing the newest research and techniques to thoughtfully care for young women with gynecologic cancers who still desire to have children or build their families. I am deeply honored to practice here at Mass General, where experts from all over the country work together and allow us to ensure each patient receives world class care.
I obtained my medical degree from Emory University and completed residency in Obstetrics & Gynecology at the combined Brigham & Women's/Massachusetts General Hospital program at Harvard. Following residency, I completed my fellowship training in Gynecologic Oncology at the Massachusetts General Hospital. Currently, I am Associate Professor at Harvard Medical School, where my research is in the science of balancing what is most important to the patient (quality of life, body function and image, reproductive outcomes and goals for their life) with what is medically required to cure their cancer or lengthen their life, a field of study known as Patient Reported Outcomes. I lecture nationally and internationally on this topic, have published over 80 peer reviewed articles and book chapters, sit on numerous national advisory boards and serve as a Co-Chair of the Quality Committee of our national governing body in Gynecologic Oncology.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Cancer Center: Gynecologic Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Suite 9E
Boston, MA 02114
Phone: 617-724-4800
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Currently, Dr. Sisodia's research interest lie in patient reported outcomes, perioperative care redesign and improving surgical outcomes of women with gynecologic malignancy.
Clark RM, et al. Thirty day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review. Gynecol Oncol 2018 August (150)270-277
Sisodia RC, Dankers C, Orav J, Joseph B, Meyers P, Wright P, St Amand D, del Carmen MG, Ferris T, Heng M, Licurse A, Meyer G, Sequist TD. Factors associated with Increased Collection of Patient Reported Outcomes within a Large Health Care System. JAMA Netw Open. 2020 April 1; 3 (4); e202764
Mou D, Sisodia RC, Castillo-Angeles M, Ladin K, Pusic A, del Carmen M, Heng, M. Surgeon’s Perceived Value of Patient Reported Outcome Measures (PROMs): An Exploratory Qualitative Study of Five Different Surgical Subspecialties. Annals of Surgery, 2020, Jul 9
Sisodia RC, Dewdney SB, Fader A, Wethington S, Melamed A, von Gruenigen V, Zivanovic O, Carter J, Cohn D, Huh W, Wenzel L, Doll K, Cella D, Dowdy S. A Society of Gynecologic Oncology White Paper: Patient Reported Outcomes Measures in Gynecologic Oncology: A primer for Clinical Use, part I. Gynecol Oncol 158 (1), 194-200
Sisodia RC, et al. . A Society of Gynecologic Oncology White Paper: Patient Reported Outcomes Measures in Gynecologic Oncology: A primer for Clinical Use, part II. Gynecol Oncol, 158 (1)201-207Kanbergs An,
Alimena S, Sullivan MW, Philp L, Dorney K, Hubbell H, del Carmen MG, Goodman AK, Bregar A, Growdon W, Eisenhauer E, Sisodia RC. Patient reported measures among patients with vulvar cancer at various stages of treatment, recurrence and survivorship. Gynecol Oncol, 2020 Oct 30: S0090-8258
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 hospital in New England based U.S. News & World Report Best Hospitals for 2022-2023.
Dr. Sisodia talks about caring for women with cancer, promoting female leaders & her work leading the collection of patient reported outcome measures.
Episode #[XX] of the Charged podcast